ArticlePDF AvailableLiterature Review

Oxygen Toxicity and Special Operations Forces Diving: Hidden and Dangerous

Frontiers
Frontiers in Psychology
Authors:

Abstract and Figures

In Special Operations Forces (SOF) closed-circuit rebreathers with 100% oxygen are commonly utilized for covert diving operations. Exposure to high partial pressures of oxygen (PO2) could cause damage to the central nervous system (CNS) and pulmonary system. Longer exposure time and higher PO2 leads to faster development of more serious pathology. Exposure to a PO2 above 1.4 ATA can cause CNS toxicity, leading to a wide range of neurologic complaints including convulsions. Pulmonary oxygen toxicity develops over time when exposed to a PO2 above 0.5 ATA and can lead to inflammation and fibrosis of lung tissue. Oxygen can also be toxic for the ocular system and may have systemic effects on the inflammatory system. Moreover, some of the effects of oxygen toxicity are irreversible. This paper describes the pathophysiology, epidemiology, signs and symptoms, risk factors and prediction models of oxygen toxicity, and their limitations on SOF diving.
Content may be subject to copyright.
MINI REVIEW
published: 25 July 2017
doi: 10.3389/fpsyg.2017.01263
Frontiers in Psychology | www.frontiersin.org 1July 2017 | Volume 8 | Article 1263
Edited by:
Costantino Balestra,
HE2B - Haute Ecole
Bruxelles-Brabant, Belgium
Reviewed by:
Jacek Kot,
Gda ´
nsk Medical University, Poland
Peter Germonpre,
Centre for Hyperbaric Oxygen
Therapy, Belgium
Guy Louis Vandenhoven,
Sports Medical Centre, Belgium
*Correspondence:
Thijs T. Wingelaar
tt.wingelaar@mindef.nl
Specialty section:
This article was submitted to
Movement Science and Sport
Psychology,
a section of the journal
Frontiers in Psychology
Received: 17 May 2017
Accepted: 11 July 2017
Published: 25 July 2017
Citation:
Wingelaar TT, van Ooij P-JAM and van
Hulst RA (2017) Oxygen Toxicity and
Special Operations Forces Diving:
Hidden and Dangerous.
Front. Psychol. 8:1263.
doi: 10.3389/fpsyg.2017.01263
Oxygen Toxicity and Special
Operations Forces Diving: Hidden
and Dangerous
Thijs T. Wingelaar 1, 2*, Pieter-Jan A. M. van Ooij1and Rob A. van Hulst 2
1Diving Medical Center, Royal Netherlands Navy, Den Helder, Netherlands, 2Department of Anaesthesiology, Academic
Medical Center, Amsterdam, Netherlands
In Special Operations Forces (SOF) closed-circuit rebreathers with 100% oxygen are
commonly utilized for covert diving operations. Exposure to high partial pressures of
oxygen (PO2) could cause damage to the central nervous system (CNS) and pulmonary
system. Longer exposure time and higher PO2leads to faster development of more
serious pathology. Exposure to a PO2above 1.4 ATA can cause CNS toxicity, leading to
a wide range of neurologic complaints including convulsions. Pulmonary oxygen toxicity
develops over time when exposed to a PO2above 0.5 ATA and can lead to inflammation
and fibrosis of lung tissue. Oxygen can also be toxic for the ocular system and may have
systemic effects on the inflammatory system. Moreover, some of the effects of oxygen
toxicity are irreversible. This paper describes the pathophysiology, epidemiology, signs
and symptoms, risk factors and prediction models of oxygen toxicity, and their limitations
on SOF diving.
Keywords: oxygen toxicity, CNS-toxicity, pulmonary toxicity, diving, closed-circuit rebreather
INTRODUCTION
Military diving, especially within the domain of the Special Operations Forces (SOF), is one of
the most extreme forms of diving. Depending on the task, this type of diving demands different
equipment, procedures and training and, therefore, it is totally unlike commercial or civilian diving.
For SOF divers, range and endurance, high mobility and stealth, are of utmost importance. To
facilitate these requirements, the most commonly used equipment is the closed-circuit oxygen
rebreather (O2-CCR): a comprehensive overview of the historic aspects of CCR diving is already
published (Donald, 1992; Acott, 1999; Butler, 2004).
A CCR is fundamentally different from any open-circuit or semi-closed diving system. Instead
of releasing exhaled air to the surrounding environment, it is recirculated within the apparatus.
Any exhaled carbon dioxide (CO2) is “scrubbed” by a chemical mixture, often various hydroxides,
for instance NaOH and Ca(OH)2. The efficacy of scrubbers is beyond the scope of this review,
but factors like granule size, ambient temperature, and humidity greatly affect and sometimes limit
scrubber efficiency. CCRs can be used with air, mixed gas, or pure oxygen. There is no exhaled
gas under the form of bubbles and gas consumption is very much limited, increasing the possible
autonomous dive time. In case of a breathing gas composed of pure oxygen, a second substantial
difference compared to a regular SCUBA or mixed gas rebreather can be noted: the oxygen diver
has no accumulation of nitrogen or other inert breathing gas and, therefore, no decompression
limits. To facilitate recirculation, the breathing gas is temporarily stored in a “counter lung” before
inspiration. The volume of this counter lung limits the tidal volume (TV) and maximum minute
Wingelaar et al. Special Operating Forces Oxygen Diving
volume (MMV) of the SOF diver. The limitation of TV and MMV
and possible saturation of the soda lime can cause retention of
CO2(Arieli et al., 2006a,b). This greatly affects the development
of oxygen toxicity (see below).
Although many studies have investigated the toxic effects
of oxygen on both the central nervous system (CNS) and
the pulmonary system, the question remains how applicable
those studies are for SOF divers. Much of the research was
conducted with animals; although this has greatly contributed
to our understanding of physiological processes, the results
cannot always be extrapolated to humans (Robinson et al., 1974;
Bryan and Jenkinson, 1988; O’Collins et al., 2006). Secondly,
much of the available data on humans is rather old, and many
of these experiments will never be replicated today due to
our current viewpoint on research ethics. Nevertheless, these
historical studies give some insight into the (life-threatening)
dangers that oxygen poses for man (Donald, 1992; Acott, 1999).
Since technological advances (such as, the capacity of “scrubbing”
CO2) influence the occurrence of oxygen toxicity, many of these
older studies cannot be used to determine the threshold or safe
limits or oxygen exposure. Lastly, most human experiments were
performed in rest in a recompression chamber, the so-called
“dry dives.” Although dry dives enable researchers to administer
oxygen in partial pressures above 1 ATA (equal to 101.3 kPa), the
effects of oxygen are not the same as in an actual dive. Several
studies have shown that submersion can alter the physiologic
reaction to breathing gases (Donald, 1992; Kerem et al., 1995; van
Ooij et al., 2011).
However, even when taking these limitations into
consideration, some relevant data on oxygen toxicity in
diving are still available. The aim of this paper is to summarize
the pathologic effects of oxygen (mainly on the CNS and
pulmonary system) and their operational consequences for SOF
divers.
CENTRAL NERVOUS SYSTEM TOXICITY
The phenomenon of CNS toxicity is commonly referred to as
the Paul Bert effect, named after the French physiologist who
first described it (Bert, 1878). In many dry dive experiments,
Bert showed that oxygen is toxic and potentially lethal for many
organic species including seeds, fungi, insects, and several small
mammals. Others published similar results, showing that CNS
toxicity was dependent on the inspired partial pressure of oxygen
(PO2) and the time exposed. In 1910 Bornstein was probably
the first to expose two human volunteers in a dry dive setting to
hyperbaric oxygen at a PO2of 2.8 ATA (equal to 283.7 kPa) for
30 min without any complaints (Acott, 1999).
The tolerance for oxygen in dry dives is much higher
than in wet dives (Donald, 1992). In an immersed setting, a
PO2above 1.4 ATA can lead to nausea, numbness, dizziness,
twitching, hearing and visual disturbances, unconsciousness and
convulsions (Harabin et al., 1995). In humans, no oxygen induced
convulsions have been described with a PO2lower than 1.3,
although susceptibility to oxygen toxicity has a high interpersonal
and intra-individual variability (Donald, 1992; Arieli et al., 2008).
While convulsions can occur without any prior symptoms, visual
disturbances generally precede convulsions (Curley and Butler,
1987; Arieli et al., 2006a). Reports on the incidence of CNS
toxicity vary greatly, ranging from 1 in 157,930 CCR dives to
approximately 3.5% of the CCR dives (Harabin et al., 1995;
Walters et al., 2000; Arieli et al., 2002). This may be attributed to
different exposures in time and depth, or to different definitions
of the symptoms or, perhaps, because the covert nature of SOF
diving precludes the reporting of precise incidences.
Pathogenesis and Risk Factors
Although the exact mechanism is not fully understood, currently,
the most plausible explanation is related to an overflow of reactive
oxygen species (ROS) in the brain after an increase of cerebral
blood flow (CBF) (Visser et al., 1996a; Koch et al., 2008). Due to
the increased PO2in plasma there is an auto oxidation of nitric
oxide (·NO) to several ROS, of which peroxynitrite (ONOO)
is the most important (Goldstein and Czapski, 1995; de Groot
et al., 2004). ROS cause angiotensin-II induced vasoconstriction
via activation of non-phagocytic NAD(P)H oxidase (Weissmann
et al., 2000; de Groot et al., 2004; Nguyen Dinh Cat et al.,
2013). However, at the same time, endothelial and neuronal
nitric oxide synthase (eNOS and nNOS), which are responsible
for vasodilatation, are increased (Hoehn et al., 2003). The net
result of both processes is vasoconstriction and a reduction
of CBF up to a certain “breaking point.” Possibly due to
depletion of the radical oxygen scavenger system, vessels dilate
and increases CBF (Chavko et al., 1998; Demchenko et al.,
2002; Eynan et al., 2014). Simultaneous to this increase in
CBF, the cortical electroencephalography (EEG) activity increases
(Bean and Coulson, 1971; Visser et al., 1996b). This increase
in CBF and cortical EEG activity precedes convulsions (Bean
and Coulson, 1971; Visser et al., 1996a,b; Demchenko et al.,
2001; Koch et al., 2008). The exact mechanism though which
ROS cause convulsions is not entirely clear. ROS are believed
to directly affect various ionic conductance that regulate cell
excitability, as well as disrupting chemical synaptic transmission
(Manning, 2016). The role of superoxide dismutase (SOD),
catalase and other scavengers in the brain, predominantly on
the function of the hippocampus, remains to be elucidated.
However, animal experiments have shown that modulating the
N-methyl-D-aspartate (NMDA) and N-nitro-L-arginine (NNA)
system alters the susceptibility (Eynan et al., 2014; Manning,
2016). When any prodromal symptoms are encountered and the
PO2is lowered, convulsions may be avoided (Arieli et al., 2008).
Despite extensive research to identify risk factors in CNS
toxicity, most studies were on animals and the relevance for
oxygen diving in humans remains unclear. Oxygen toxicity is
dependent on both PO2and time, i.e., the time of onset of
symptoms is shorter when the PO2is higher (Donald, 1992;
Arieli et al., 2002). An increase in end-tidal partial pressure of
carbon dioxide (PetCO2), either by “CO2retainers” (divers with
a delayed or altered response to hypercapnia) or due to exercise,
also increases susceptibility to oxygen toxicity (Arieli et al., 2001;
Koch et al., 2013). Dehydration and starvation prolongs the latent
period to onset of convulsion in rats, but the pathophysiological
mechanism is unclear (Bitterman et al., 1997). In a small study,
Frontiers in Psychology | www.frontiersin.org 2July 2017 | Volume 8 | Article 1263
Wingelaar et al. Special Operating Forces Oxygen Diving
a ketogenic diet in divers increased oxygen tolerance, but the
mechanism for neuroprotection remains unknown (Valadao
et al., 2014). Adding nitrogen or helium to the inspired gas, as
well as adding periods of breathing air (commonly called “air
breaks”) to the oxygen exposure, protect against convulsions
in dry dives, but the feasibility in oxygen diving is limited
(Hendricks et al., 1977; Bitterman et al., 1987; Harabin et al.,
1988; Arieli et al., 2005, 2008). An overview of pharmacological
agents and vitamins that protect or sensitize has recently been
published (Jain, 2017). A few pharmacological agents are worth
mentioning here: scopolamine and cinnarizine (agents frequently
used to prevent and treat motion sickness) do not seem to either
attenuate or sensitize oxygen toxicity (Bitterman et al., 1991;
Arieli et al., 1999). Caffeine is effective in delaying convulsions in
rats, but its efficacy in humans has yet to be confirmed (Bitterman
and Schaal, 1995). Due to the unpredictability and operational
limitations, relying on pharmacological agents for extending SOF
diving is not currently relevant.
Prediction Model and Variability
The first prediction model (published by Harabin et al.) was based
on 661 CCR dives (Harabin et al., 1995). This was later refined by
Arieli et al. who based their model on 2,039 CCR dives and which
remains the most accurate model to date (Arieli et al., 2002). The
chance of oxygen toxicity (as Z-score in a normal distribution)
in any dive can be estimated by: Z=[ln(t)9.63 +3.38 ×
ln(PO2)]/2.02. Note that this equation includes PO2(in kPa) and
time (in min) as variables. The recovery time (similar to “surface
interval” in air dives: the time for a diver to neutralize the oxygen
stress) is based on experiments in rats and estimated by: Kt=Ke
×e0,079t, where Ktis regarded as a cumulative oxygen toxicity
index at time t(in min) and Kethe “toxicity dose” at the end of
exposure. However, to our knowledge, no studies have tested the
efficacy of these models in humans.
Although the methodology of the model is sound, a
considerable intra and interpersonal variability in oxygen toxicity
still remains. In an effort to identify the military divers at risk, the
“oxygen tolerance test” has long been advocated, where subjects
were exposed to breathing 100% oxygen at 2.8 ATA for 30 min
(Butler and Knafelc, 1986). However, after evaluation, this was
proven obsolete because it lacked predictive value and many
navies now refrain from using this test (Visser et al., 1996b;
Walters et al., 2000). A similar test for CO2, the Read test, has
also proven ineffective (Arieli et al., 2014). Although the ability
to detect CO2by divers can be trained, it is unknown whether
this reduces the incidence of oxygen toxicity (Eynan et al., 2003,
2005). To our knowledge no valid test is available to screen for
oxygen tolerance.
Operational Consequences
Even though the pathophysiological mechanisms and risk factors
are not yet clarified, there is a clear depth (PO2) and time
relationship. Oxygen toxicity of the CNS is a rare but potentially
life-threatening complication of exposure to high PO2, which
can occur without prodromal symptoms. If mild symptoms
do occur and can be timely recognized, convulsions may
be avoided by reducing depth. However, delayed progression
to convulsions after reducing oxygen exposure have been
described.
In sports diving, the PO2limit recommendations ranges
from 1.4 to 1.6 ATA (Lang, 2001). The limits for military
SOF diving are different, due to differences in the equipment
and the amount of “acceptable risk” (Table 1) (Vann, 1988;
United States Department of the Navy NSSC, 2008). The
model from Arieli et al. allows 24 min at a PO2of 2.5
ATA when accepting a risk of maximum 5% of CNS toxicity
(Arieli et al., 2002). The widely used US Navy Diving
Manual allows a single-depth exposure to a PO2of 2.5 ATA
for 10 min (United States Department of the Navy NSSC,
2008). However, these high risks are only taken with the
proper training, equipment and safety precautions, and only
when the operational demands leave no alternative options.
Incidence reports of oxygen toxicity using the Arieli model
are lacking, most likely due to the covert nature of SOF
diving.
PULMONARY OXYGEN TOXICITY
In 1899, the Scottish pathologist, James Lorrain Smith, published
the pathological effects of increased inspiratory oxygen tension
on several small animals (Lorrain Smith, 1899). In these classic
experiments, mice and larks were exposed to increasing pressures
of oxygen for long periods of time. Besides several episodes
of CNS toxicity, most of the animals perished because of
hypoxia as a result of insufficient ventilation due to acute or
chronic lung inflammation. Compared to CNS toxicity, a lower
partial pressure of oxygen is required to cause symptoms, but
the exposure time has to be much longer (hours to days).
Exposure above 0.5 ATA is regarded as potentially damaging
for the pulmonary system. In humans, early symptoms include
tracheobronchial irritation with retrosternal pain and coughing
(Klein, 1990). Longer exposures damage the tracheal mucosa
with impaired mucus clearance (Sackner et al., 1975). These
complaints precede changes in lung function tests, such as, a
decrease in vital capacity (VC), but have a low predictive value
due to high variability (Klein, 1990). The incidence in divers is
unknown, since no studies have investigated the epidemiology.
TABLE 1 | Single-depth oxygen exposures.
Depth
(fsw/msw)
Limit US Navy
(United States Department
of the Navy NSSC, 2008)
(min)
Risk of CNS
toxicity (Arieli
et al., 2002)(%)
Limit Arieli
et al. <5%
(min)
25/7.7 240 13.1 83
30/9.2 80 6.3 63
35/10.7 25 2.4 48
40/12.3 15 1.7 38
50/15.3 10 1.8 24
Depth in feet of sea water (fsw) and meters of sea water (msw). The limits are printed as in
the US Navy Diving Manual with (in the third column) their associated risk for CNS toxicity
based on the model of Arieli et al. (2002). The last column shows the bottom time when
accepting a maximum risk of CNS toxicity of 5%.
Frontiers in Psychology | www.frontiersin.org 3July 2017 | Volume 8 | Article 1263
Wingelaar et al. Special Operating Forces Oxygen Diving
Pathophysiology and Risk Factors
Pulmonary oxygen toxicity (POT) can be divided into two phases.
The first exsudative phase (Figure 2, left side) is marked by local
inflammation with capillary and endothelial edema, a decrease of
type I alveolar cells, and an influx of inflammatory cells (Miller
and Winter, 1981; Bryan and Jenkinson, 1988; Demchenko et al.,
2007). These changes are reversible and the lung returns to
its normal state (Figure 1) if the inspired oxygen pressure is
reduced below 0.5 ATA. In the following proliferative phase
(Figure 2, right side) fibroblasts and type II alveolar cells infiltrate
the inflamed endothelia. With continuing inflammation, this
ultimately leads to alveolar fibrosis and a four- to fivefold increase
of thickness of the air-blood membrane and, as a consequence,
loss of diffusion capacity (Kapanci et al., 1972; Robinson et al.,
1974). These changes are irreversible. The rate at which these
changes occur is directly related to the inspired PO2and can
occur as early as 3 h at a PO2of 3 ATA during a dry dive (Winter
and Smith, 1972; Klein, 1990).
When divers are immersed, many physiologic processes
are altered. Circulating volume is redistributed due to the
hydrostatic pressure on the body and peripheral vasoconstriction
when immersed in cold water, both resulting in volume shift
and intrathoracic pooling (Norsk et al., 1985; Choukroun
et al., 1989; Pendergast and Lundgren, 2009). Even though
the mammalian diving reflex lowers the heart rate, the net
result of both processes is pulmonary hypertension, because the
cardiac output is increased as a result of the Frank-Starling
mechanism (Dahlback et al., 1978). The increased blood flow
in the lung recruits apical fields (compared to exercise), but
also stiffens the lung (Choukroun et al., 1983; Pendergast and
FIGURE 1 | Schematic representation of the normal alveolocapillary region. 1,
alveolar type 1 cell; 2, alveolar type 2 cell; 3, basement membrane; 4,
interstitium; 5, capillary endothelial cell; 6, fibroblast; 7, alveolar macrophage;
8, surfactant layer; 9, red blood cell; 10, capillary base membrane. Adapted
with permission from van Ooij et al. (2013).
Lundgren, 2009). Beside these effects on lung circulation, the
intrathoracic pooling and pulmonary hypertension triggers the
baroreceptors in the right atrium, which increases diuresis
through an increased vasopressin release (Norsk et al., 1986;
Boussuges et al., 2007, 2009). Lastly, the position of the diver
in the water (horizontal or vertical) and the position of the
breathing apparatus compared to the body (deeper or lower than
the diver) also influences perfusion of the lung and breathing
dynamics (Badeer, 1982; Taylor and Morrison, 1991). As a result
of all of the above processes, gas exchange in the lung during
immersion is substantially different from that during dry dives
(Prefaut et al., 1978; Taylor and Morrison, 1990; van Ooij et al.,
2011).
Very few studies have reported risk factors for developing
POT in divers, let alone in SOF divers. Most of the results are
derived from dry dive experiments. Many of these studies use a
decrease in VC as a marker to determine the amount of POT;
however, the validity of this measurement is questioned (see
below). Shykoff reported that exercise in an immersed setting
and repeated exposure increases POT (Shykoff, 2008a,b). To our
knowledge, no other risk factors have been identified. In animal
studies, scavengers (such as, SOD and catalase) were shown
to protect lung tissue against the overload of oxygen radicals;
however, this effect has not been confirmed in humans (Kimball
et al., 1976; Frank et al., 1978; Potter et al., 1999).
Prediction Model and Variability
In military and commercial diving, the current standard for
determining the maximum pulmonary oxygen exposure in
FIGURE 2 | Exsudative stage (left) and proliferative stage (right) in pulmonary
oxygen toxicity. 1, type 1 alveolar cell; 2, type 2 alveolar cell; 3, alveolar
edema; 4, neutrophil; 5, hyaline membrane; 6, edematous interstitium; 7,
fibroblast; 8, fibrin thrombus; 9, swollen capillary endothelial cell; 10, denuded
basement membrane; 11, alveolar fibrin formation; 12, collagen fibers
deposition; 13, incorporation of hyaline membrane; 14, fibroblastic
proliferation; 15, interstitial fibrin.
Frontiers in Psychology | www.frontiersin.org 4July 2017 | Volume 8 | Article 1263
Wingelaar et al. Special Operating Forces Oxygen Diving
diving is “units of pulmonary toxicity dose” (UPTD). One UTPD
equals the amount of damage caused by breathing 1 min of
100% oxygen at 1 ATA (Bardin and Lambertsen, 1970). The
basic concept of UPTD is that a certain threshold (amount of
oxygen molecules) is required to cause local damage, which can
be measured by a decrease in VC. For instance, an exposure of
615 UPTD causes the VC to decrease 2% in 50% of the divers,
while 1425 UPTD lowers the VC by 10% in 50% of the divers
(Clark and Lambertsen, 1970; Wright, 1972). Since the 1970s,
many studies have further refined the basic model (Clark et al.,
1999). To calculate the amount of UPTD, the following equation
must be solved: UPTD =t×[0.5/(PO20.5)]5/6, with PO2in
ATA and time in minutes. Arieli et al. published an improved
equation to more accurately determine the decrease in VC in
a dry setting, based on data from several studies that included
exposures with humans: 1VC =0.0082 ×t2(PO2/101.3)4.57;
please note that, here, PO2is in kPa and time is in hours
(Eckenhoff et al., 1987; Clark et al., 1991; Arieli et al., 2002).
The “cumulative units of pulmonary toxicity dose” (CPTD), the
“oxygen toxicity unit” (OTU) and derived equation for repetitive
exposure (REPEX) were introduced to include recovery and
facilitate multi-day exposures, but was never validated in divers
(Hamilton, 1989). Arieli et al. also published an updated equation
to estimate the recovery of lung volume, which was extrapolated
from data derived from animal experiments performed in a dry
setting (Arieli et al., 2002). There is no consensus which model is
the most valid to plan SOF operations.
The main flaw in the UPTD concept and the derived equations
is the change in VC as the sole indicator to determine oxygen
stress. VC has a circadian rhythm and there is a strong intra and
interpersonal variability when measuring lung volumes (Hruby
and Butler, 1975; Harabin et al., 1987). Ventilation during
anaesthesiology with a high PO2is known to influence VC,
possibly due to absorption atelectasis (O’Brien, 2013). Whether
this also occurs in SOF divers, or how long this endures after
diving, is unknown. Recent findings have proven that immersion
itself alters VC regardless of oxygen stress (Shykoff, 2005; van
Ooij et al., 2011, 2012). Since the UPTD model was derived
from dry dives, the above-mentioned factors are not taken into
account. Although the original authors recognized the limitations
of the UPTD model, more advanced diagnostic measurements
were either too difficult to perform or were unavailable in the
1960s/1970s (Bardin and Lambertsen, 1970).
Operational Consequences
POT is more insidious than CNS toxicity; it affects the
oxygen divers in long shallow-water dives or when recurrently
exposed. The current prediction model (UPTD) was developed
in dry setting during a time when capabilities to measure
lung parameters were limited. Newer parameters, such as, the
ratio between diffusion capacity of carbon monoxide and nitric
oxide (DLNO/CO), fraction of exhaled nitric oxide (FENO ) or
volatile organic compounds (VOCs), might be more accurate
in determining POT, but these tests have yet to be validated
(Shykoff, 2008a,b; Caspersen et al., 2011; van Ooij et al., 2014b,a,
2016; Vermeulen et al., 2016). Especially the VOCs are of interest
because, in the field of pulmonology, this noninvasive diagnostic
modality is increasingly utilized for diagnosing asthma, acute
respiratory distress syndrome and lung cancer (Bos et al., 2014,
2016; Boots et al., 2015). However, until a new valid parameter to
determine POT has been established, the UPTD model remains
the gold standard, despite its limitations.
As equipment improves and dive times are extended, SOF
divers might be increasingly exposed to a level at which
irreversible damage may occur. The Royal Netherlands Navy
currently dives with the LAR 5010 by Dräger and within the
limits given by NATO (Allied Diving Publication), which are
highly similar to the US Navy Diving Manual (United States
Department of the Navy NSSC, 2008). Oxygen exposure is
limited to 450 UPTD per day and 2250 UPTD per week. A
single exposure up to 1425 UPTD is regarded the absolute
maximum and only to be used in exceptional circumstances
with sufficient medical support available (i.e., recompression
facilities and medical capacity within the operational theater).
The Royal Netherlands Navy Diving Medical Center performs
yearly dive medicals on all Dutch SOF divers according to and
surpassing the standard of the European Diving Technology
Committee (Wendling and Nome, 2004). In a recent 20-year
longitudinal cohort study, we found no significant changes
in pulmonary function and diffusion capacity of SOF divers
compared to other Navy divers or non-divers (Voortman et al.,
2016). Tetzlaff et al. published similar results (Tetzlaff et al.,
2005). Yearly exercise tolerance testing shows VO2 max values
regularly surpassing 50 ml/kg/min and all divers remain fit for
diving duties during their career. This may be due to either
sufficient “recovery” time between extreme dives, or because
exposures are not severe enough to cause irreversible damage.
Although current monitoring does not show any deleterious
effects, it remains necessary to continue this monitoring of long
term health effects as the level of exposure in recent years has
increased.
OTHER PATHOPHYSIOLOGIC CHANGES
While CNS toxicity and pulmonary toxicity have been described
as separate entities in this review, their occurrence may be
more closely related. In addition to cold, stress and physical
activity, CNS toxicity activates the sympathetic nervous system,
which in animal experiments leads to pulmonary edema though
the pulmonary venule adrenergic hypersensitivity response
(Winklewski et al., 2013). Hyperoxia, even at normobaric
conditions, induces many physiological changes which are often
not fully understood. In addition, the clinical relevance of these
changes and impact on SOF diving remains to be elucidated.
Although this paper does not aim to give a full review of all
known pathophysiological effects of oxygen in divers, the effects
on sight and exercise tolerance are important in the context of
SOF diving. For further reading of the effects of hyperoxia on
other parts of the body we suggest the work of Bennett and Elliott
(Brubakk and Neuman, 2003).
Ocular Toxicity
Visual acuity is of crucial importance to SOF divers. Visual
complaints are a frequent side-effect of daily clinical treatments
Frontiers in Psychology | www.frontiersin.org 5July 2017 | Volume 8 | Article 1263
Wingelaar et al. Special Operating Forces Oxygen Diving
in recompression chambers (hyperbaric oxygen therapy: HBOT).
Transient myopia with up to 0.25 dioptres loss for each week
exposed to high oxygen pressures can occur, but generally
resolves after a few weeks (Butler et al., 2008). Apart from
one case report, hyperopic myopia has not been reported in
oxygen divers (Butler et al., 1999). Although extreme HBOT
exposures can cause irreversible cataract or keratoconus, this has
not been described in divers (Palmquist et al., 1984; Butler, 1995;
McMonnies, 2015). These effects of oxygen on the ocular system
are probably irrelevant for SOF divers, as oxygen pressures are
generally much lower and exposure is less frequent compared
with daily HBOT in patients for several weeks.
Exercise Tolerance
There are several reports on fatigue and reduced exercise
tolerance after high oxygen exposures (Comroe et al., 1945;
Lambertsen, 1978; Shykoff, 2005). Divers complained about
retrosternal pain or the inability to “give their full” for several
days. To what extent this is a subjective complaint, or limits
(diving) performance, is unknown. Although the mechanism
behind these complaints is not fully understood, generalized
oxidative stress depletes the scavenger system and leads to
lipid peroxidation of the cell membranes causing cell damage
(Ferrer et al., 2007; Perovic et al., 2014). After diving, because
there is an upregulation of glutathione peroxidase (GPx) and
catalase activity in lymphocytes, the inflammatory system may
also be involved (Ferrer et al., 2007). Damage and dysfunction
of erythrocytes has been described after hyperbaric hyperoxic
exposure and in saturation divers, its effect on exercise tolerance
is unknown (Dise et al., 1987; Hofsø et al., 2005). To what
extend performance is impaired in SOF divers after oxygen diving
remains to be confirmed.
SUMMARY
In diving and hyperbaric environments, oxygen toxicity has been
a topic of interest for over a century. Although many human
experiments are not reflecting current equipment or procedures
anymore, the results do illustrate the damaging potential of
oxygen. Diving with high partial pressures of oxygen can result
in acute life-threatening neurologic complications or irreversible
pulmonary structural changes. However, the extent to which
these problems occur in oxygen diving remains unknown, due
to the lack of studies on humans during immersion, and/or
epidemiologic studies.
In SOF diving, where 100% oxygen rebreathing diving systems
are frequently used, operational demands and health risks are
taken into account when planning dives. All current limits
or diving tables with high PO2possess a certain quantity of
“acceptable” risk. The question arises as to whether civilian or
commercial divers should use the same limits as SOF divers.
To develop more accurate prediction models, we need to
identify the pathophysiological mechanism of oxygen toxicity
and the factors that, subsequently, increase or decrease the
risk to various parts of the body. This is complicated by
the covert nature of SOF diving, limiting publication of
data. Also, in view of the considerable inter- and intra-
personal variability, perhaps the future of oxygen diving
requires real-time individual monitoring of early symptoms
of oxygen toxicity, such as, CBF or exhaled VOCs, to
protect humans from the harmful effects of oxygen when
diving.
Current Limits on Oxygen Exposure in the
Royal Netherlands Navy
Central Nervous System Oxygen Toxicity
Divers exposed to a PO2above 1.3 ATA should be considered
to be at risk for developing CNS toxicity. An estimation of
the chance of CNS toxicity in diving, as Z-value in a normal
distribution with tin minutes and PO2in kPa, can be made
(Arieli et al., 2002). There is no consensus regarding a “maximum
acceptable risk.”
Z=ln (t)9.63 +3.38 ×ln(PO2)
2.02 (1)
Pulmonary Oxygen Toxicity
Any PO2above 0.5 ATA is regarded as toxic for the
pulmonary system. The amount of “units of pulmonary
toxicity dose” (UPTD), with tin minutes and PO2in ATA,
can be calculated with the function below (Bardin and
Lambertsen, 1970). Many authorities regard an exposure of
615 UPTD as the “maximum safe exposure for a single
dive”.
UPTD =t1.2s0.5
PO20.5 (2)
AUTHOR CONTRIBUTIONS
TW student of RvH: Acquisition and review of literature,
drafting, and revising manuscript. PJvO co-promotor of TW:
Review of literature, help with theoretical framework, writing,
and reviewing concept manuscripts. RvH promotor of TW:
Review of literature, help with theoretical framework, writing,
and reviewing concept manuscripts.
FUNDING
This research received no specific grant from any funding
agency in the public, commercial, or not-for-profit
sectors.
REFERENCES
Acott, C. (1999). Oxygen toxicity: a brief history of oxygen in diving. SPUMS J. 29,
150–155.
Arieli, R., Arieli, Y., Daskalovic, Y., Eynan, M., and Abramovich, A.
(2006a). CNS oxygen toxicity in closed-circuit diving: signs and
symptoms before loss of consciousness. Aviat. Space Environ. Med. 77,
1153–1157.
Frontiers in Psychology | www.frontiersin.org 6July 2017 | Volume 8 | Article 1263
Wingelaar et al. Special Operating Forces Oxygen Diving
Arieli, R., Ertracht, O., Oster, I., Vitenstein, A., and Adir, Y. (2005). Effects of
nitrogen and helium on CNS oxygen toxicity in the rat. J. Appl. Physiol. 98,
144–150. doi: 10.1152/japplphysiol.00506.2004
Arieli, R., Eynan, M., Ofir, D., and Arieli, Y. (2014). Brief screening
test of ventilatory sensitivity to CO(2) cannot replace the mandatory
test for susceptibility to CNS oxygen toxicity. Mil. Med. 179, 926–932.
doi: 10.7205/MILMED-D-14-00026
Arieli, R., Rashkovan, G., Moskovitz, Y., and Ertracht, O. (2001). PCO threshold
for CNS oxygen toxicity in rats in the low range of hyperbaric PO. J. Appl.
Physiol. 91, 1582–1587.
Arieli, R., Shochat, T., and Adir, Y. (2006b). CNS toxicity in closed-circuit oxygen
diving: symptoms reported from 2527 dives. Aviat. Space Environ. Med. 77,
526–532.
Arieli, R., Shupak, A., Shachal, B., Shenedrey, A., Ertracht, O., and Rashkovan, G.
(1999). Effect of the anti-motion-sickness medication cinnarizine on central
nervous system oxygen toxicity. Undersea Hyperb. Med. 26, 105–109.
Arieli, R., Truman, M., and Abramovich, A. (2008). Recovery from central nervous
system oxygen toxicity in the rat at oxygen pressures between 100 and 300 kPa.
Eur. J. Appl. Physiol. 104, 867–871. doi: 10.1007/s00421-008-0843-2
Arieli, R., Yalov, A., and Goldenshluger, A. (2002). Modeling pulmonary and
CNS O toxicity and estimation of parameters for humans. J. Appl. Physiol. 92,
248–256. doi: 10.1152/japplphysiol.00434.2001
Badeer, H. S. (1982). Gravitational effects on the distribution of pulmonary
blood flow: hemodynamic misconceptions. Respiration 43, 408–413.
doi: 10.1159/000194511
Bardin, H., and Lambertsen, C. J. (1970). A Quantitative Method for Calculating
Pulmonary Toxicity: Use of the ’Unit Pulmonary Toxicity Dose’ (UPTD).
Philadelphia, PA: Institute for Environmental Medicine; University of
Pennsylvania.
Bean, J. W. L., and J., Coulson, J. (1971). Regional cerebral blood flow, O2, and
EEG in exposures to O2at high pressure. J. Appl. Physiol. 31, 235–242.
Bert, P. (1878). La Pression Barométrique: Recherches de Physiologie Expérimentale.
Paris: Masson.
Bitterman, N., Eilender, E., and Melamed, Y. (1991). Hyperbaric oxygen and
scopolamine. Undersea Biomed. Res. 18, 167–174.
Bitterman, N., Laor, A., and Melamed, Y. (1987). CNS oxygen toxicity in oxygen-
inert gas mixtures. Undersea Biomed. Res. 14, 477–483.
Bitterman, N., and Schaal, S. (1995). Caffeine attenuates CNS oxygen toxicity in
rats. Brain Res. 696, 250–253. doi: 10.1016/0006-8993(95)00820-G
Bitterman, N., Skapa, E., and Gutterman, A. (1997). Starvation and
dehydration attenuate CNS oxygen toxicity in rats. Brain Res. 761, 146–150.
doi: 10.1016/S0006-8993(97)00442-3
Boots, A. W., Bos, L. D., van der Schee, M. P., van Schooten, F. J., and
Sterk, P. J. (2015). Exhaled molecular fingerprinting in diagnosis and
monitoring: validating volatile promises. Trends Mol. Med. 21, 633–644.
doi: 10.1016/j.molmed.2015.08.001
Bos, L. D., Sterk, P. J., and Fowler, S. J. (2016). Breathomics in the setting of
asthma and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol.
138, 970–976. doi: 10.1016/j.jaci.2016.08.004
Bos, L. D., Weda, H., Wang, Y., Knobel, H. H., Nijsen, T. M., Vink, T.
J., et al. (2014). Exhaled breath metabolomics as a noninvasive diagnostic
tool for acute respiratory distress syndrome. Eur. Respir. J. 44, 188–197.
doi: 10.1183/09031936.00005614
Boussuges, A., Gole, Y., Mourot, L., Jammes, Y., Melin, B., Regnard, J., et al. (2009).
Haemodynamic changes after prolonged water immersion. J. Sports Sci. 27,
641–649. doi: 10.1080/02640410902717001
Boussuges, A., Molenat, F., Grandfond, A., Regnard, J., Wolf, J. P., Galland, F.,
et al. (2007). Cardiovascular changes induced by cold water immersion during
hyperbaric hyperoxic exposure. Clin. Physiol. Funct. Imaging 27, 268–274.
doi: 10.1111/j.1475-097X.2007.00747.x
Brubakk, A., and Neuman, T. (2003). Bennett and Elliotts’ Physiology and Medicine
of Diving. Eastbourne: Saunders Ltd.
Bryan, C. L., and Jenkinson, S. G. (1988). Oxygen toxicity. Clin. Chest Med. 9,
141–152.
Butler, F. K. (1995). Diving and hyperbaric ophthalmology. Surv. Ophthalmol. 39,
347–366. doi: 10.1016/S0039-6257(05)80091-8
Butler, F. K. (2004). Closed-circuit oxygen diving in the U.S. Navy. Undersea
Hyperb. Med. 31, 3–20.
Butler, F. K., Hagan,C., and Murphy-L avoie,H. (2008). Hyperbaric oxygen therapy
and the eye. Undersea Hyperb. Med. 35, 333–387.
Butler, F. K., and Knafelc, M. E. (1986). Screening for oxygen intolerance in U.S.
Navy divers. Undersea Biomed. Res. 13, 91–98.
Butler, F. K., White, E., and Twa, M. (1999). Hyperoxic myopia in a closed-circuit
mixed-gas scuba diver. Undersea Hyperb. Med. 26, 41–45.
Caspersen, C., Stensrud, T., and Thorsen, E. (2011). Bronchial nitric oxide flux
and alveolar nitric oxide concentration after exposure to hyperoxia. Aviat. Space
Environ. Med. 82, 946–950. doi: 10.3357/ASEM.2995.2011
Chavko, M., Braisted, J. C., Outsa, N. J., and Harabin, A. L. (1998). Role of cerebral
blood flow in seizures from hyperbaric oxygen exposure. Brain Res. 791, 75–82.
doi: 10.1016/S0006-8993(98)00083-3
Choukroun, M. L., Guenard, H., and Varene, P. (1983). Pulmonary capillary blood
volume during immersion in water at different temperatures. Undersea Biomed.
Res. 10, 331–342.
Choukroun, M. L., Kays, C., and Varene, P. (1989). Effects of water temperature on
pulmonary volumes in immersed human subjects. Respir. Physiol. 75, 255–265.
doi: 10.1016/0034-5687(89)90036-4
Clark, J. M., Jackson, R. M., Lambertsen, C. J., Gelfand, R., Hiller,W. D., and Unger,
M. (1991). Pulmonary function in men after oxygen breathing at 3.0 ATA for
3.5 h. J. Appl. Physiol. 71, 878–885.
Clark, J. M., and Lambertsen, C. J. (1970). Pulmonary Oxygen Tolerance in
Man and Derivation of Pulmonary Oxygen Tolerance Curves. Institute for
Environmental Medicine; University of Pennsylvania Medical Center.
Clark, J. M., Lambertsen, C. J., Gelfand, R., Flores, N. D., Pisarello, J. B., Rossman,
M. D., et al. (1999). Effects of prolonged oxygen exposure at 1.5, 2.0, or 2.5
ATA on pulmonary function in men (predictive studies V). J. Appl. Physiol. 86,
243–259.
Comroe, J. H., Dripps, R. D., Dumke, P. R., and Deming, M. (1945). Oxygen
toxicity. JAMA 128, 710–717. doi: 10.1001/jama.1945.02860270012004
Curley, M. D., and Butler, F. K. (1987). Visualreaction time performance preceding
CNS oxygen toxicity. Undersea Biomed. Res. 14, 301–310.
Dahlback, G. O., Jonsson, E., and Liner, M. H. (1978). Influence of hydrostatic
compression of the chest and intrathoracic blood pooling on static lung
mechanics during head-out immersion. Undersea Biomed. Res. 5, 71–85.
de Groot, A. A., van Zwieten, P. A., and Peters, S. L. (2004). Involvement of reactive
oxygen species in angiotensin II-induced vasoconstriction. J. Cardiovasc.
Pharmacol. 43, 154–159. doi: 10.1097/00005344-200401000-00023
Demchenko, I. T., Boso, A. E., Whorton, A. R., and Piantadosi, C. A. (2001). Nitric
oxide production is enhanced in rat brain before oxygen-induced convulsions.
Brain Res. 917, 253–261. doi: 10.1016/S0006-8993(01)03057-8
Demchenko, I. T., Oury, T. D., Crapo, J. D., and Piantadosi, C. A. (2002).
Regulation of the brain’s vascular responses to oxygen. Circ.Res. 91, 1031–1037.
doi: 10.1161/01.RES.0000043500.03647.81
Demchenko, I. T., Welty-Wolf, K. E., Allen, B. W., and Piantadosi, C. A. (2007).
Similar but not the same: normobaric and hyperbaric pulmonary oxygen
toxicity, the role of nitric oxide. Am. J. Physiol. Lung Cell. Mol. Physiol. 293,
L229–L238. doi: 10.1152/ajplung.00450.2006
Dise, C. A., Clark, J. M., Lambersten, C. J., and Goodman, D. B. (1987). Hyperbaric
hyperoxia reversibly inhibits erythrocyte phospholipid fatty acid turnover. J.
Appl. Physiol. 62, 533–538.
Donald, K. (1992). Oxygen and the Diver. Welshpool: The SPA Ltd.
Eckenhoff, R. G., Dougherty, J. H. Jr., Messier, A. A., Osborne, S. F., and Parker,
J. W. (1987). Progression of and recovery from pulmonary oxygen toxicity in
humans exposed to 5 ATA air. Aviat. Space Environ. Med. 58, 658–667.
Eynan, M., Arieli, R., and Adir, Y. (2005). Response to CO2in novice closed-circuit
apparatus divers and after 1 year of active oxygen diving at shallow depths. J.
Appl. Physiol. 98, 1653–1659. doi: 10.1152/japplphysiol.00660.2004
Eynan, M., Daskalovic, Y. I., Arieli, Y., Arieli, R., Shupak, A., Eilender, E., et al.
(2003). Training improves divers’ ability to detect increased CO2.Aviat. Space
Environ. Med. 74, 537–545.
Eynan, M., Krinsky, N., Biram, A., Arieli, Y., and Arieli, R. (2014). A
comparison of factors involved in the development of central nervous
system and pulmonary oxygen toxicity in the rat. Brain Res. 1574, 77–83.
doi: 10.1016/j.brainres.2014.05.051
Ferrer, M., Sureda, A., Battle, J., Tauler, P., Tur, J., and Pons, A. (2007). Scuba diving
enhances endogenous antioxidant defenses in lymphcytes and neutrophils. Free
Radic. Res. 41, 274–281. doi: 10.1080/10715760601080371
Frontiers in Psychology | www.frontiersin.org 7July 2017 | Volume 8 | Article 1263
Wingelaar et al. Special Operating Forces Oxygen Diving
Frank, L., Bucher, J. R., and Roberts, R. J. (1978). Oxygen toxicity in neonatal and
adult animals of various species. J. Appl. Physiol. 45, 699–704.
Goldstein, S., and Czapski, G. (1995). Kinetics of nitric oxide autoxidation in
aqueous solution in the absence and presence of various reductants. The
nature of the oxidizing intermediates. J. Am. Chem. Soc. 117, 12078–12084.
doi: 10.1021/ja00154a007
Hamilton, R. W. (1989). Tolerating exposure to high oxygen levels: repex and other
methods. Mar. Technol. Soc. 23, 19–25.
Harabin, A. L., Homer, L. D., Weathersby, P. K., and Flynn, E. T. (1987). An
analysis of decrements in vital capacity as an index of pulmonary oxygen
toxicity. J. Appl. Physiol. 63, 1130–1135.
Harabin, A. L., Survanshi, S. S., and Homer, L. D. (1995). A model for predicting
central nervous system oxygen toxicity from hyperbaric oxygen exposures in
humans. Toxicol. Appl. Pharmacol. 132, 19–26. doi: 10.1006/taap.1995.1082
Harabin, A. L., Survanshi, S. S., Weathersby, P. K., Hays, J. R., and Homer, L. D.
(1988). The modulation of oxygen toxicity by intermittent exposure. Toxicol.
Appl. Pharmacol. 93, 298–311. doi: 10.1016/0041-008X(88)90130-5
Hendricks, P. L., Hall, D. A., Hunter, W. L. Jr., and Haley, P. J. (1977). Extension of
pulmonary O2tolerance in man at 2 ATA by intermittent O2exposure. J. Appl.
Physiol. 42, 593–599.
Hoehn, T., Felderhoff-Mueser, U., Maschewski, K., Stadelmann, C., Sifringer, M.,
Bittigau, P., et al. (2003). Hyperoxia causes inducible nitric oxide synthase-
mediated cellular damage to the immature rat brain. Pediatr. Res. 54, 179–184.
doi: 10.1203/01.PDR.0000075220.17631.F1
Hofsø, D., Ulvik, R. J., Segadal, K., Hope, A., and Thorsen, E. (2005). Changes
in erythropoietin and haemoglobin concentrations in response to saturation
diving. Eur. J. Appl. Physiol. 95, 191–196. doi: 10.1007/s00421-005-1381-9
Hruby, J., and Butler, J. (1975). Variability of routine pulmonary function tests.
Thorax 30, 548–553. doi: 10.1136/thx.30.5.548
Jain, K. (2017). Textbook of Hyperbaric Medicine,6th Edn. Cham: Springer
International Publishing.
Kapanci, Y., Tosco, R., Eggermann, J., and Gould, V. E. (1972). Oxygen
pneumonitis in man., Light- and electron-microscopic morphometric studies.
Chest 62, 162–169. doi: 10.1378/chest.62.2.162
Kerem, D., Daskalovic, Y. I., Arieli, R., and Shupak, A. (1995). CO2retention
during hyperbaric exercise while breathing 40/60 nitrox. Undersea Hyperb.
Med. 22, 339–346.
Kimball, R. E., Reddy, K., Peirce, T. H., Schwartz, L. W., Mustafa, M. G., and
Cross, C. E. (1976). Oxygen toxicity: augmentation of antioxidant defense
mechanisms in rat lung. Am. J. Physiol. 230, 1425–1431.
Klein, J. (1990). Normobaric pulmonary oxygen toxicity. Anesth. Analg. 70,
195–207. doi: 10.1213/00000539-199002000-00012
Koch, A. E., Koch, I., Kowalski, J., Schipke, J. D., Winkler, B. E., Deuschl, G.,
et al. (2013). Physical exercise might influence the risk of oxygen-induced acute
neurotoxicity. Undersea Hyperb. Med. 40, 155–163.
Koch, A., Kähler, W., Wegner-Bröse, H., Weyer, D., Kuhtz-Buschbeck, J.,
Deuschl, G., et al. (2008). Monitoring of CBFV and time characteristics
of oxygen-induced acute CNS toxicity in humans. Eur. J. Neurol. 746–748.
doi: 10.1111/j.1468-1331.2008.02158.x
Lambertsen, C. J. (1978). Effects of Hyperoxia on Organs and Their Tissues.
Philadelphia, PA: Institute for Environmental Medicine; University of
Pennsylvania.
Lang, M. A. (ed.). (2001). “Nitrox operational data,” in Proceedings of the
DANNitrox Workshop (Durham, NC: Divers Alert Network), 197.
Lorrain Smith, J. (1899). The pathological effects due to increase of oxygen tension
in the air breathed. J. Physiol. 24, 19–35. doi: 10.1113/jphysiol.1899.sp000746
Manning, E. P. (2016). Central nervous system oxygen toxicity and
hyperbaric oxygen seizures. Aerospace Med. Hum. Perform. 87, 477–486.
doi: 10.3357/AMHP.4463.2016
McMonnies, C. W. (2015). Hyperbaric oxygen therapy and the possibility of
ocular complications or contraindications. Clin. Exp. Optom. 98, 122–125.
doi: 10.1111/cxo.12203
Miller, J. N., and Winter, P. M. (1981). Clinical manifestations of
pulmonary oxygen toxicity. Int. Anesthesiol. Clin. 19, 179–199.
doi: 10.1097/00004311-198119030-00011
Nguyen Dinh Cat, A., Montezano, A. C., Burger, D., and Touyz, R. M. (2013).
Angiotensin II, NADPH oxidase, and redox signaling in the vasculature.
Antioxid. Redox Signal. 19, 1110–1120. doi: 10.1089/ars.2012.4641
Norsk, P., Bonde-Petersen, F., and Warberg, J. (1985). Central venous pressure
and plasma arginine vasopressin during water immersion in man. Eur. J. Appl.
Physiol. Occup. Physiol. 54, 71–78. doi: 10.1007/BF00426302
Norsk, P., Bonde-Petersen, F., and Warberg, J. (1986). Arginine vasopressin,
circulation, and kidney during graded water immersion in humans. J. Appl.
Physiol. 61, 565–574.
O’Brien, J. (2013). Absorption atelectasis: incidence and clinical implications.
AANA J. 81, 205–208.
O’Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, B.
H., and Howells, D. W. (2006). 1,026 experimental treatments in acute stroke.
Ann. Neurol. 59, 467–477. doi: 10.1002/ana.20741
Palmquist, B. M., Philipson, B., and Barr, P. O. (1984). Nuclear cataract and
myopia during hyperbaric oxygen therapy. Br. J. Ophthalmol. 68, 113–117.
doi: 10.1136/bjo.68.2.113
Pendergast, D. R., and Lundgren, C. E. (2009). The underwater environment:
cardiopulmonary, thermal, and energetic demands. J. Appl. Physiol. 106,
276–283. doi: 10.1152/japplphysiol.90984.2008
Perovic, P., Unic, A., and Dumic, J. (2014). Recreational scuba diving: negative
or positive effects of oxidative and cardiovascular stress? Biochem. Med. 24,
235–247. doi: 10.11613/BM.2014.026
Potter, C. F., Kuo, N. T., Farver, C. F., McMahon, J. T., Chang, C. H., Agani,
F. H., et al. (1999). Effects of hyperoxia on nitric oxide synthase expression,
nitric oxide activity, and lung injury in rat pups. Pediatr. Res. 45, 8–13.
doi: 10.1203/00006450-199901000-00003
Prefaut, C., Ramonatxo, M., Boyer, R., and Chardon, G. (1978). Human
gas exchange during water immersion. Respir. Physiol. 34, 307–318.
doi: 10.1016/0034-5687(78)90130-5
Robinson, F. R., Casey, H. W., and Weibel, E. R. (1974). Animal model: oxygen
toxicity in nonhuman primates. Am. J. Pathol. 76, 175–178.
Sackner, M. A., Landa, J., Hirsch, J., and Zapata, A. (1975). Pulmonary effects of
oxygen breathing. A 6-hour study in normal men. Ann. Intern. Med. 82, 40–43.
doi: 10.7326/0003-4819-82-1-40
Shykoff, B. E. (2005). Pulmonary effects of submerged oxygen breathing: 4-, 6-, and
8-hour dives at 140 kPa. Undersea Hyperb. Med. 32, 351–361.
Shykoff, B. E. (2008a). Pulmonary effects of submerged exercise while breathing
140 kPa oxygen. Undersea Hyperb. Med. 35, 417–426.
Shykoff, B. E. (2008b). Pulmonary effects of submerged oxygen breathing in resting
divers: repeated exposures to 140 kPa. Undersea Hyperb. Med. 35, 131–143.
Taylor, N. A., and Morrison, J. B. (1990). Effects of breathing-gas pressure on
pulmonary function and work capacity during immersion. Undersea Biomed.
Res. 17, 413–428.
Taylor, N. A., and Morrison, J. B. (1991). Lung volume changes in response to
altered breathing gas pressure during upright immersion. Eur. J. Appl. Physiol.
Occup. Physiol. 62, 122–129. doi: 10.1007/BF00626767
Tetzlaff, K., Friege, L., Theysohn, J., Neubauer, B., and Muth, C. M. (2005). Lung
function in military oxygen divers: a longitudinal study. Aviat. Space Environ.
Med. 76, 974–977.
United States Department of the Navy NSSC (2008). United States Department of
the Navy NSSC. U.S. Navy Diving Manual.
Valadao, J. M., Vigilante, J. A., DiGeorge, N. W., O’Connor, S. E., Bear, A., Kenyon,
J., et al. (2014). Ketogenic diet for high partial pressure oxygen diving. Undersea
Hyperb. Med. 41, 331–335.
Vann, R. (1988). Oxygen Toxicity Risk Assessment. Durham, NC: Department of
Anesthesiology; Duke Medical Center,
van Ooij, P. A., Sterk, P. J., and van Hulst, R. A. (2016). Oxygen, the
lung and the diver: friends and foes? Eur. Respir. Rev. 25, 496–505.
doi: 10.1183/16000617.0049-2016
van Ooij, P. J., Hollmann, M. W., van Hulst, R. A., and Sterk, P. J. (2013).
Assessment of pulmonary oxygen toxicity: relevance to professional diving; a
review. Respir. Physiol. Neurobiol. 189, 117–128. doi: 10.1016/j.resp.2013.07.014
van Ooij, P. J., van Hulst, R. A., Houtkooper, A., and Sterk, P. J. (2011).
Differences in spirometry and diffusing capacity after a 3-h wet or dry
oxygen dive with a PO of 150 kPa. Clin. Physiol. Funct. Imaging 31, 405–410.
doi: 10.1111/j.1475-097X.2011.01034.x
van Ooij, P. J., van Hulst, R. A., Houtkooper, A., and Sterk, P. J. (2014a). Nitric
oxide and carbon monoxide diffusing capacity after a 1-h oxygen dive to
9 m of sea water. Clin. Physiol. Funct. Imaging 34, 199–208. doi: 10.1111/cpf.
12082
Frontiers in Psychology | www.frontiersin.org 8July 2017 | Volume 8 | Article 1263
Wingelaar et al. Special Operating Forces Oxygen Diving
van Ooij, P. J., van Hulst, R. A., Houtkooper, A., vander Weide, T. J., and Sterk, P. J.
(2012). Lung function before and after oxygen diving: a randomized crossover
study. Undersea Hyperb. Med. 39, 699–707.
van Ooij, P. J., van Hulst, R. A., Kulik, W., Brinkman, P., Houtkooper, A.,
and Sterk, P. J. (2014b). Hyperbaric oxygen diving affects exhaled molecular
profiles in men. Respir. Physiol. Neurobiol. 198, 20–24. doi: 10.1016/j.resp.2014.
03.009
Vermeulen, M., Ooij, P. J. A. M., and Nemery, B. (2016). Comparison of Vital
Capacity and Expiratory Volatile Organic Compounds in Detection of Oxidative
Lung Damage after Hyperbaric Exposure: an Experimental Study. University of
Leuven.
Visser, G. H., Van Hulst, R. A., Wieneke, G. H., and Van Huffelen, A. C. (1996a).
Transcranial doppler sonographic measurements of middle cerebral artery
flow velocity during hyperbaric oxygen exposures. Undersea Hyperb. Med. 23,
157–165.
Visser, G. H., van Hulst, R. A., Wieneke, G. H., and van Huffelen, A. C. (1996b). The
contribution of conventional and quantitative electroencephalography during
monitoring of exposure to hyperbaric oxygen. Undersea Hyperb. Med. 23,
91–98.
Voortman, M., Ooij P. J. A. M., Van Hulst, R. A., and Zanen, P. (2016). Pulmonary
function changes in Navy divers during their professional careers. Undersea
Hyperb. Med. 43, 649–657.
Walters, K. C., Gould, M. T., Bachrach, E. A., and Butler, F. K. (2000). Screening
for oxygen sensitivity in U.S. Navy combat swimmers. Undersea Hyperb. Med.
27, 21–26.
Weissmann, N., Tadic, A., Hanze, J., Rose, F., Winterhalder, S., Nollen, M., et al.
(2000). Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-
derived H(2)O(2) ?Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L683–L690.
Wendling, J. E. D., and Nome, T. (2004). Medical Assessment of Working Divers.
Fitness to Dive Standards of European Diving Technology Committee,1st Edn.,
Biele-Biene: Hyperbaric Editions.
Winklewski, P. J., Kot, J., Frydrychowski, A. F., Nuckowska, M. K., and Tkachenko,
Y. (2013). Effects of diving and oxygen on autonomic nervous system and
cerebral blood flow. Diving Hyperb Med. 43, 148–56.
Winter, P. M., and Smith, G. (1972). The toxicity of oxygen. Anesthesiology 37,
210–241. doi: 10.1097/00000542-197208000-00010
Wright, W. B. (1972). Use of the University of Pennsylvania, Institute for
Environmental Medicine Procedure for Calculation of Cummulative Pulmonary
Oxygen Toxicity. Washington, DC: Navy Experimental Diving Unit.
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Wingelaar, van Ooij and van Hulst. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Psychology | www.frontiersin.org 9July 2017 | Volume 8 | Article 1263
... These patterns play a significant role in neurological disorders, such as those affecting consciousness. The rhythm (8)(9)(10)(11)(12) is the prominent EEG wave pattern of an awake and relaxed adult, and its amplitudes decrease upon eyes opening and during movement. rhythm (13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30) occurs during alertness, attentiveness, and specific mental efforts and, finally Hz) is correlated with cognitive processes. ...
... In the context of hyperbaric conditions, human tolerance to oxygen in dry dives is higher than in wet dives, and symptoms can range from nausea to convulsions at 2 above 1.4 atmosphere absolute pressure (ATA) in an immersed setting. Oxygen-induced convulsions have not been reported in humans below 2 levels of 1.3 ATA, but susceptibility to toxicity can vary between individuals [9]. For example, Rostain and colleagues [3] found that during a dive to 450 m seawater with the helium-nitrogen-oxygen gas mixture, there was a decrease in frequencies around 100 m and an increase in frequencies in the frontal area around 200 m. ...
... Although diver's ability to detect CO 2 can be trained, it is unknown if this reduces the incidence of oxygen toxicity [49]. To date, no valid test exists to screen for oxygen tolerance [9]. ...
... Гипероксия используется в тренировочном процессе для повышения работоспособности и выносливости при физических нагрузках и для устранения эффекта перетренированности [5,6]. Вместе с тем многократное применение сеансов дыхания кислородом под повышенным давлением в организме, не испытывающем дефицит кислорода, ставит вопрос о возможности развития токсического хроноконцентрационного действия [1,7,8]. При этом одной из основных мишеней токсического действия кислорода являются структуры ЦНС [7][8][9]. ...
... Вместе с тем многократное применение сеансов дыхания кислородом под повышенным давлением в организме, не испытывающем дефицит кислорода, ставит вопрос о возможности развития токсического хроноконцентрационного действия [1,7,8]. При этом одной из основных мишеней токсического действия кислорода являются структуры ЦНС [7][8][9]. Хотя полностью механизм токсичности кислорода не изучен, в настоящее время наиболее правдоподобное объяснение связывают с избытком активных форм кислорода в головном мозге после увеличения мозгового кровотока [8]. ...
... При этом одной из основных мишеней токсического действия кислорода являются структуры ЦНС [7][8][9]. Хотя полностью механизм токсичности кислорода не изучен, в настоящее время наиболее правдоподобное объяснение связывают с избытком активных форм кислорода в головном мозге после увеличения мозгового кровотока [8]. ...
Article
Full-text available
OBJECTIVE. Study the effect of a single and multiple administration of hyperbaric oxygenation (HBO) in the therapeutic regime on the processes of lipid peroxidation (LPO) and enzyme of antioxidative defense in phylogenetically various structures of the brain in the period of the immediate and remote aftereffect of expositions. MATERIALS AND METHODS. Experiments were carried out on 87 nonlinear white male rats weighing 180-230 grams. Hyperbaric oxygenation was conducted by medical oxygen in the experimental pressure chamber in the “mild” mode (2 ata, 50 min isopression), 1 session per day in the morning. The study was carried out after 1, 5, 10 sessions, in 5 and 10 days after 1 session and in 5 days after 5 sessions of HBO. The content of malondialdehyde (MDA) was determined in the brain stem, cerebellum and large brain hemispheres. The state of an enzyme element of antioxidant defense was evaluated by superoxide dismutase (SOD) and catalase. RESULTS. It was found that exposure to oxygen under high pressure caused increased intensity of LPO processes in the brain that progresses from 1 to 5 sessions. While MDA changes in the brain stem were detected later than in the hemispheres and cerebellum. LPO intensification in the brain proceeded against the background of increased activity of SOD. After 10 sessions of HBO LPO intensity decreased that was confirmed by reduced MDA content and SOD activity in examined brain tissue. Catalase activity reduced in the stem after 5 sessions and increased in the cerebellum and hemispheres after 10 sessions of HBO. Aftereffect of 1 HBO session was characterized by persistent increase in MDA concentration in the brain regions, detected in 5 and 10 days after exposure and was accompanied by increased SOD activity against the background of reduced catalase activity. In 5 days after 5 sessions the increase in MDA content and SOD activation was observed only in the tissue of the cerebral hemispheres. DISCUSSION. The use of HBO in the mode 2 ata, 50 min stimulates reactions of free radical oxidation (FRO) in the brain. The dynamics of their development with continued exposure shows that there are enough resources of the brain antioxidant defense to compensate hyperoxic load, including 10-fold exposure and no depletion of the reserves of enzyme antioxidant element in the brain is observed. After a single exposure of hyperbaric oxygen FRO activation remains during 10 days that can be concluded from an increased level of MDA and an increased activity of SOD in all the brain regions against the background of reduced catalase activity of stem structures and cerebellum. Repeated 5-fold exposures have a shorter metabolic “footprint”: in 5 days LPO effect and SOD activation are less pronounced than in the period of 1 session aftereffect both in 5 and 10 days. CONCLUSION. The therapeutic “mild” mode of HBO (2 ata, 50 min, 1 session per day) causes FRO activation in the brain tissue of experimental animals. Its intensity is controlled by the activation of enzyme protection mechanisms that is enough to compensate FRO changes with this mode of hyperoxic load. After ending exposures more pronounced aftereffect of HBO in the brain regions is found after 1 session compared to 5 sessions.
... Clinically, POT presents as tracheobronchiolitis causing coughing, pleuritic chest pain, and dyspnea [7]. Clinical diagnosis is challenging due to a lack of unique objective findings: oftentimes, the only identifiable change in pulmonary function is a highly variable decrease in vital capacity (VC) [8,9]. Other measures of pulmonary function, such as forced mid-expiratory flow and diffusion capacity (DC), have been proposed as more sensitive markers of HBOT damage, however none of these are highly specific [10]. ...
... (101-304 kPa) [23][24][25][26]. These changes correspond to two descriptions of two discrete phases of acute POT based on pathology of the lower respiratory tract: an acute, exudative phase characterized by reversible capillary endothelial cell damage, parenchymal edema, and the infiltration of inflammatory cells [27]; and a subacute, proliferative phase in which type II pneumocytes and fibroblasts multiply and cause irreversible derangement of the lung architecture, including marked thickening of the blood-air barrier and pulmonary fibrosis with impaired gas exchange [9,28]. ...
... In order to quantify POT, a unit of pulmonary toxic dose (UPTD) has been introduced to predict impairment of pulmonary function [29]. As an example, hyperoxic exposures might be limited to 450 UPTD per day and 2250 UPTD per week [9] where each UPTD is the equivalent of one minute at 1 ATA (101 kPa) of 100% O 2 . However, this model has several limitations including a need for cumulative dose calculations to account for periods of recovery between exposures, hence alternative metrics such as a POT index have been proposed [30]. ...
Article
Full-text available
Hyperbaric oxygen therapy (HBOT) is known to be associated with pulmonary oxygen toxicity. However, the effect of modern HBOT protocols on pulmonary function is not completely understood. The present study evaluates pulmonary function test changes in patients undergoing serial HBOT. We prospectively collected data on patients undergoing HBOT from 2016–2021 at a tertiary referral center (protocol registration NCT05088772). Patients underwent pulmonary function testing with a bedside spirometer/pneumotachometer prior to HBOT and after every 20 treatments. HBOT was performed using 100% oxygen at a pressure of 2.0–2.4 atmospheres absolute (203–243 kPa) for 90 minutes, five times per week. Patients’ charts were retrospectively reviewed for demographics, comorbidities, medications, HBOT specifications, treatment complications, and spirometry performance. Primary outcomes were defined as change in percent predicted forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and forced mid-expiratory flow (FEF25-75), after 20, 40, and 60 HBOT sessions. Data was analyzed with descriptive statistics and mixed-model linear regression. A total of 86 patients were enrolled with baseline testing, and the analysis included data for 81 patients after 20 treatments, 52 after 40 treatments, and 12 after 60 treatments. There were no significant differences in pulmonary function tests after 20, 40, or 60 HBOT sessions. Similarly, a subgroup analysis stratifying the cohort based on pre-existing respiratory disease, smoking history, and the applied treatment pressure did not identify any significant changes in pulmonary function tests during HBOT. There were no significant longitudinal changes in FEV1, FVC, or FEF25-75 after serial HBOT sessions in patients regardless of pre-existing respiratory disease. Our results suggest that the theoretical risk of pulmonary oxygen toxicity following HBOT is unsubstantiated with modern treatment protocols, and that pulmonary function is preserved even in patients with pre-existing asthma, chronic obstructive lung disease, and interstitial lung disease.
... Patients who undergo treatment with a COMEX-30 table inhale a gas mixture of 50% helium and 50% oxygen to mitigate the risk of oxygen toxicity, an adverse effect of breathing a gas mix with an increased partial pressure of oxygen (pO 2 ). Oxygen toxicity has been characterized as central nervous system oxygen toxicity (CNS-OT) or pulmonary oxygen toxicity (POT), depending on the pO 2 and the duration of hyperoxic exposure [8]. The initial symptoms of CNS-OT have been reported at a pO 2 of 1.3-1.6 atmosphere absolute (ATA), whereas the first symptoms of POT have been found to occur at 0.5 ATA [9]. ...
... The GC-MS output was processed for peak detection, denoising, and retention time alignment, as described previously [8,20,[23][24][25]. Significant differences in ion fragments per retention time were compared between the baseline measurement and the measurements after hyperbaric exposure by Wilcoxon signed-rank tests. ...
Article
Full-text available
The COMEX-30 hyperbaric treatment table is used to manage decompression sickness in divers but may result in pulmonary oxygen toxicity (POT). Volatile organic compounds (VOCs) in exhaled breath are early markers of hyperoxic stress that may be linked to POT. The present study assessed whether VOCs following COMEX-30 treatment are early markers of hyperoxic stress and/or POT in ten healthy, nonsmoking volunteers. Because more oxygen is inhaled during COMEX-30 treatment than with other treatment tables, this study hypothesized that VOCs exhaled following COMEX-30 treatment are indicators of POT. Breath samples were collected before and 0.5, 2, and 4 h after COMEX-30 treatment. All subjects were followed-up for signs of POT or other symptoms. Nine compounds were identified, with four (nonanal, decanal, ethyl acetate, and tridecane) increasing 33–500% in intensity from before to after COMEX-30 treatment. Seven subjects reported pulmonary symptoms, five reported out-of-proportion tiredness and transient ear fullness, and four had signs of mild dehydration. All VOCs identified following COMEX-30 treatment have been associated with inflammatory responses or pulmonary diseases, such as asthma or lung cancer. Because most subjects reported transient pulmonary symptoms reflecting early-stage POT, the identified VOCs are likely markers of POT, not just hyperbaric hyperoxic exposure.
... Moreover, as psychotropic medications could increase susceptibility to nitrogen narcosis or oxygen toxicity, a limitation on diving depth, e.g., 18 metres (60 feet), could be recommended to prevent these conditions. 30 ...
Article
This review discusses the safety concerns associated with diving while using psychotropic medication and the limited literature available on the topic. Despite the risks, some divers continue to dive while taking these medications, and their reasons for doing so are unclear. The exact mechanisms of action of these drugs in hyperbaric environments are poorly understood. While current standards and advice for fitness-to-dive assessments are based on limited evidence and expert opinion, developing evidence-based strategies could improve patient care and optimise diving safety. This review appraises relevant literature in diving medicine and provides clinical perspectives for diving physicians conducting fitness-to-dive assessments on patients using psychotropic medication.
... The toxic effects of oxygen upon the lungs were discovered more than a century ago [35]. POT can be divided into two phases, an early exudative and a late proliferative phase [36]. These two phases have been experienced clinically by most intensivists treating ARDS patients, where the early phase is reversible and the latter, which leads to fibrosis, is irreversible if the oxygen fraction cannot be lowered below a toxic dose [37]. ...
Article
Full-text available
Background: A few prospective trials and case series have suggested that hyperbaric oxygen therapy (HBOT) may be efficacious for the treatment of severe COVID-19, but safety is a concern for critically ill patients. We present an interim analysis of the safety of HBOT via a randomized controlled trial (COVID-19-HBO). Methods: A randomized controlled, open-label, clinical trial was conducted in compliance with good clinical practice to explore the safety and efficacy of HBOT for severe COVID-19 in critically ill patients with moderate acute respiratory distress syndrome (ARDS). Between 3 June 2020, and 17 May 2021, 31 patients with severe COVID-19 and moderate-to-severe ARDS, a ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2) < 26.7 kPa (200 mmHg), and at least two defined risk factors for intensive care unit (ICU) admission and/or mortality were enrolled in the trial and randomized 1:1 to best practice, or HBOT in addition to best practice. The subjects allocated to HBOT received a maximum of five treatments at 2.4 atmospheres absolute (ATA) for 80 min over seven days. The subjects were followed up for 30 days. The safety endpoints were analyzed. Results: Adverse events (AEs) were common. Hypoxia was the most common adverse event reported. There was no statistically significant difference between the groups. Numerically, serious adverse events (SAEs) and barotrauma were more frequent in the control group, and the differences between groups were in favor of the HBOT in PaO2/FiO2 (PFI) and the national early warning score (NEWS); statistically, however, the differences were not significant at day 7, and no difference was observed for the total oxygen burden and cumulative pulmonary oxygen toxicity dose (CPTD). Conclusion: HBOT appears to be safe as an intervention for critically ill patients with moderate-to-severe ARDS induced by COVID-19. Clinical trial registration: NCT04327505 (31 March 2020) and EudraCT 2020-001349-37 (24 April 2020).
... Although this is acutely necessary and successfully addresses hypoxemia and tissue hypoxia, the detrimental effects of oxygen toxicity necessitate that it be administered with caution (Perrone et al. 2017). In non-clinical settings, examples of operational exposure to hyperoxia include military and recreational divers (van Ooij et al. 2016;Wingelaar et al. 2017) and astronauts (Thirsk et al. 2009). In these situations as well, the inherent toxicity of oxygen necessitates that exposure to hyperoxia be limited. ...
Article
Full-text available
In clinical settings, oxygen therapy is administered to preterm neonates and to adults with acute and chronic conditions such as COVID-19, pulmonary fibrosis, sepsis, cardiac arrest, carbon monoxide poisoning, and acute heart failure. In non-clinical settings, divers and astronauts may also receive supplemental oxygen. In addition, under current standard cell culture practices, cells are maintained in atmospheric oxygen, which is several times higher than what most cells experience in vivo. In all the above scenarios, the elevated oxygen levels (hyperoxia) can lead to increased production of reactive oxygen species from mitochondria, NADPH oxidases, and other sources. This can cause cell dysfunction or death. Acute hyperoxia injury impairs various cellular functions, manifesting ultimately as physiological deficits. Chronic hyperoxia, particularly in the neonate, can disrupt development, leading to permanent deficiencies. In this review, we discuss the cellular activities and pathways affected by hyperoxia, as well as strategies that have been developed to ameliorate injury. Graphical abstract • Hyperoxia promotes overproduction of reactive oxygen species (ROS). • Hyperoxia dysregulates a variety of signaling pathways, such as the Nrf2, NF-κB and MAPK pathways. • Hyperoxia causes cell death by multiple pathways. • Antioxidants, particularly, mitochondria-targeted antioxidants, have shown promising results as therapeutic agents against oxygen toxicity in animal models.
Article
Hyperbaric oxygen (HBO) refers to pure oxygen with a pressure greater than 1 atmospheres absolute (ATA), and when the pressure is too high, it can cause convulsive attacks. Adenosine and dopamine have been shown to be closely associated with HBO induced convulsion seizures, and their receptors exhibited a coexisting relationship of mutual antagonism on the membrane of nerve cells. We explored the influence of adenosine and dopamine interplay on the occurrence of oxygen convulsion. Rats were individually exposed to HBO of 6 ATA and treated with adenosine, dopamine, and their receptor modulators separately and jointly, with the latency of convulsion onset recorded. Additionally, after administering adenosine to rats and exposing them to HBO for 30 min, the content of dopamine and its metabolites, as well as the activity of enzymes related to their metabolism, were measured. The results revealed that dopamine was effective in resisting convulsion (> 60 min vs 32.53±5.31 min, P=0.000), and low-dose adenosine partially counteracted its effect (> 60 min vs 28.18±6.24 min, P=0.002). The combined use of adenosine A1 and dopamine D1 receptor modulators significantly impacted the incidence of convulsion. The activation or inhibition of A2A receptor had a particularly significant impact on convulsion, while modulating D2 receptor did not affect their effects. The combination of A1 agonist and D2 agonist was highly effective in resisting convulsion (> 60 min vs 32.53±5.31 min, P=0.000). Exposure to HBO accelerated the metabolism of dopamine to its end products, which may be related to the enhanced activity of monoamine oxidase (MAO). Adenosine can inhibit MAO activity (0.0766±0.0150 U/mg.prot vs 0.1055±0.0086 U/mg.prot, P=0.004), maintaining a higher level of dopamine (1.820±0.379 mg/g vs 0.602±0.087 mg/g, P=0.000). The study demonstrated that dopamine plays a significant role in oxygen convulsion, and adenosine can affect dopamine metabolism. The interaction between them can have a crucial impact on the occurrence of oxygen convulsion. The findings offer a novel perspective for further investigating the mechanism of oxygen convulsion and exploring effective preventive strategies.
Chapter
In the current chapter, the effects of normobaric and hyperbaric oxygenation on brain activities will be discussed. The reported results are ranging from the monitoring of 1–2 parameter up to 10 parameters using a multiparametric monitoring system located inside the hyperbaric chamber. Very few studies were performed while monitoring brain functions and mitochondrial redox state under hyperbaric oxygenation. Therefore, this chapter will provide most of the published data available.
Article
Full-text available
INTRODUCTION: The relevance of this issue is due to the fact that nowadays there is no common understanding of the influence degree of high partial oxygen pressures on a body functions’ state, depending on individual resistance. OBJECTIVE: Research the state of the functions of the central nervous, cardiovascular and respiratory systems among people with different resistance to the toxic oxygen effect in the descending and the nearest post-descending period. MATERIALS AND METHODS: There was an examination of 11 divers aged 23 to 43 (the average age is 35.5±6.5 years) in conditions of a simulated descent in a pressure chamber to the depth of 15 m (0.25 MPa) while breathing oxygen, and also during 3 days after its termination. Statistic: Software SPSS, v. 20.0 (IBM) was applied for statistical processing of the results. RESULTS: Baseline heart rate (HR) in the low toxic oxygen resistant group (group I) is 10% (р<0.05) higher than the subjects, recognized as resistant (group II). To 60 minutes oxygen breathing (pO2=0.25 MPa) there is a decrease in heart rate (HR) by 12.5% in group I and 11% in group II, comparing the baseline (р><0.05). An increase of diastolic pressure level in group II is 10.5% to 15 min descent and 18% to 45 min, comparing the baseline (р><0.05). In group I the pulse pressure level reduced by 18%, comparing the baseline (р><0.05). Gencha test results after descent rose by 55% in group I and by 62.5% in group II, comparing the baseline (р�0.05), and indicators higher than initial remained for 3 days more. In group I there was reduction of information processing speed by a visual analyzer of 16% (from 0.788 to 0.661 b/sec) and increase in escape latency of a simple visual-motor reaction by 11.7%, comparing the baseline (р><0.05). DISCUSSION: Divers with different resistance to the toxic oxygen effect experience multidirectional reaction of the central nervous, cardiovascular and respiratory systems. Individuals, resistant to the toxic oxygen effect, are characterized by more active inclusion of counteraction mechanisms to hyperoxia and significant reduction in the level of adaptation reserves and the efficiency of the cardiovascular system. People with low resistance experience a decrease in the functionality level of the central nervous system. CONCLUSION: The results obtained have a basis for admitting the application of the method of determining individual body resistance to the toxic oxygen effect and tests with increasing dosed physical activity in order to estimate adaptation reserves and efficiency. >< 0.05) higher than the subjects, recognized as resistant (group II). To 60 minutes oxygen breathing (pO2=0.25 MPa) there is a decrease in heart rate (HR) by 12.5% in group I and 11% in group II, comparing the baseline (р< 0.05). An increase of diastolic pressure level in group II is 10.5% to 15 min descent and 18% to 45 min, comparing the baseline (р< 0.05). In group I the pulse pressure level reduced by 18%, comparing the baseline (р< 0.05). Gencha test results after descent rose by 55% in group I and by 62.5% in group II, comparing the baseline (р 0.05), and indicators higher than initial remained for 3 days more. In group I there was reduction of information processing speed by a visual analyzer of 16% (from 0.788 to 0.661 b/sec) and increase in escape latency of a simple visual-motor reaction by 11.7%, comparing the baseline (р< 0.05). DISCUSSION: Divers with different resistance to the toxic oxygen effect experience multidirectional reaction of the central nervous, cardiovascular and respiratory systems. Individuals, resistant to the toxic oxygen effect, are characterized by more active inclusion of counteraction mechanisms to hyperoxia and significant reduction in the level of adaptation reserves and the efficiency of the cardiovascular system. People with low resistance experience a decrease in the functionality level of the central nervous system. CONCLUSION: The results obtained have a basis for admitting the application of the method of determining individual body resistance to the toxic oxygen effect and tests with increasing dosed physical activity in order to estimate adaptation reserves and efficiency.
Article
Full-text available
Introduction: In divers, conflicting results regarding the development of small airway disease and “large lungs” have been reported. Purpose: To analyze the changes in pulmonary function over time, the development of “large lungs” and to see whether the pulmonary function deviates from subjects with “non-large lungs.” Methods: It is a longitudinal cohort study from 1983 till 2013 in professional navy divers, in which lung functions tests were performed annually. Results: In 1,260 navy divers, 8,149 pulmonary function tests were analyzed. e forced expiratory volume (FEV1) did not change except initially in those with abnormally low lung function (baseline value <lower-limit-of-normal for the general population (LLN). In that group, FEV1 increased by 35 (SE 7) ml/year. For the entire cohort, the inspiratory vital capacity (iVC) increased by 73 ml/year (SE 25). In the <LLN cohort, it increased by an additional 40 ml/year (SE 18). For the entire cohort, the FEV1/iVC annual drop was 0.37% (SE 0.9), but in the <LLN cohort it increased by 0.25%/year (SE 0.04). For the entire cohort, the forced expiratory ow at 75% of expir- ation (FEF75) annual drop was 23 ml/s/year (SE 7), in contrast in the <LLN cohort it increased by an addi- tional 45 ml/second/year (SE 7). Of the Navy divers, 6.3% showed “large lungs,” but changes over time were not di erent from above except for an additional 0.2% (SE 0.1%) decline in FEV1/iVC. Conclusion: In professional navy divers, long-term pulmonary function changes (FEV1 and FEV1 /iVC and FEF75) are not di erent from those in the non-diving population. e iVC increases probably due to training e ect.
Article
Full-text available
Worldwide, the number of professional and sports divers is increasing. Most of them breathe diving gases with a raised partial pressure of oxygen ( P O 2 ). However, if the P O 2 is between 50 and 300 kPa (375–2250 mmHg) (hyperoxia), pathological pulmonary changes can develop, known as pulmonary oxygen toxicity (POT). Although in its acute phase, POT is reversible, it can ultimately lead to non-reversible pathological changes. Therefore, it is important to monitor these divers to prevent them from sustaining irreversible lesions. This review summarises the pulmonary pathophysiological effects when breathing oxygen with a P O 2 of 50–300 kPa (375–2250 mmHg). We describe the role and the limitations of lung function testing in monitoring the onset and development of POT, and discuss new techniques in respiratory medicine as potential markers in the early development of POT in divers.
Article
Full-text available
Exhaled breath contains thousands of volatile organic compounds (VOCs) that reflect the metabolic process occurring in the host both locally in the airways and systemically. They also arise from the environment and the airway microbiome. Comprehensive analysis of breath VOCs (breathomics) provides opportunities for non-invasive biomarker discovery and novel mechanistic insights. Applications in obstructive lung diseases, such as asthma and COPD, include not only diagnostics (especially in children and other challenging diagnostic areas) but also the identification of clinical treatable traits such as airway eosinophilia and risk of infection/exacerbation that are not specific to diagnostic labels. Whilst many aspects of breath sampling and analysis are challenging, proof of concept studies with mass-spectrometry and electronic noses technologies have provided independent studies with moderate to good diagnostic- and phenotypic accuracies. The present review evaluates the data obtained by breathomics in: a) predicting the inception of asthma or COPD, b) inflammatory phenotyping, c) predicting exacerbations and d) treatment stratification. The current findings merit the current efforts step of large multi-centre studies, using standardized sampling, shared anaytical methods and databases, including external validation cohorts. This will position this non-invasive technology in the clinical assessment and monitoring of chronic airways diseases.
Article
Full-text available
INTRODUCTION: The use of hyperbaric oxygen (O2) as a therapeutic agent carries with it the risk of central nervous system (CNS) O2 toxicity. METHODS: To further the understanding of this risk and the nature of its molecular mechanism, a review was conducted on the literature from various fields. RESULTS: Numerous physiological changes are produced by increased partial pressures of oxygen (Po2), which may ultimately result in CNS O2 toxicity. The human body has several equilibrated safeguards that minimize effects of reactive species on neural networks, believed to play a primary role in CNS O2 toxicity. Increased partial pressure of oxygen (Po2) appears to saturate protective enzymes and unfavorably shift protective reactions in the direction of neural network overstimulation. Certain regions of the CNS appear more susceptible than others to these effects. Failure to decrease the elevated Po2 can result in a tonic-clonic seizure and death. Randomized, controlled studies in human populations would require a multicenter trial over a long period of time with numerous endpoints used to identify O2 toxicity. CONCLUSIONS: The mounting scientific evidence and apparent increase in the number of hyperbaric O2 treatments demonstrate a need for further study in the near future. Manning EP. Central nervous system oxygen toxicity and hyperbaric oxygen seizures. Aerosp Med Hum Perform. 2016; 87(5):477–486.
Article
Neonatal and adult animals of five species were exposed to 95+% O2. Survival time and changes in lung antioxidant enzyme activity (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GP)) in response to hyperoxia were determined. Adult animals succumbed to O2 lung toxicity in 3--5 days. Neonatal rats, mice and rabbits showed minimal lung changes after 7 days of hyperoxic exposure and these same neonatal animals showed rapid and significant increases in lung antioxidant enzyme activities. In contrast, neonatal guinea pigs and hamsters had no lung antioxidant enzyme response to hyperoxia and these neonates died in 95+% O2 as readily as their respective parent animals. Results from an in vitro hyperoxic exposure system suggest that the lack of enzymic response of the guinea pig (and hamster) neonates to O2 challenge is due to an inherent pulmonary biochemical unresponsiveness rather than to a deficiency of a necessary “serum factor.” The results of this species and age study support the important role of the lung antioxidant enzyme defense system in protection of the lung from O2-induced injury.
Book
This comprehensive volume captures the latest scientific evidence, technological advances, treatments and impact of biotechnology in hyperbaric oxygen therapy. Divided into three distinct sections, the book begins with basic aspects that include history, equipment, safety and diagnostic approaches; this is followed by clinical applications for hyperbaric oxygen therapy in various modalities; the last section provides an overview of hyperbaric medicine as a specialty with best practices from around the world. Integration of multidisciplinary approaches to complex disorders are also covered. Updated and significantly expanded from previous editions, Textbook of Hyperbaric Medicine, 6th Edition will continue to be the definitive guide to this burgeoning field for students, trainees, physicians and specialists.
Article
Medical diagnosis and phenotyping increasingly incorporate information from complex biological samples. This has promoted the development and clinical application of non-invasive metabolomics in exhaled air (breathomics). In respiratory medicine, expired volatile organic compounds (VOCs) are associated with inflammatory, oxidative, microbial, and neoplastic processes. After recent proof of concept studies demonstrating moderate to good diagnostic accuracies, the latest efforts in breathomics are focused on optimization of sensor technologies and analytical algorithms, as well as on independent validation of clinical classification and prediction. Current research strategies are revealing the underlying pathophysiological pathways as well as clinically-acceptable levels of diagnostic accuracy. Implementing recent guidelines on validating molecular signatures in medicine will enhance the clinical potential of breathomics and the development of point-of-care technologies. Regarding metabolomics in exhaled air, the clinical application of VOCs for diagnosing and phenotyping holds most potential. VOCs can serve as non-invasive biomarkers of inflammatory, oxidative and neoplastic processes.Separating VOCs based on source is not always mandatory, but depends on the application. Although understanding the biochemical pathway underlying a VOC is required for pathophysiological understanding, probabilistic analysis of exhaled breath already exhibits diagnostic accuracy.Breath sampling affects the exhaled VOC spectrum and requires standardization. To this end, two international initiatives are currently under development.To fulfill the clinical promise of breathomics, the currently-available studies showing moderate to good diagnostic accuracy demand external validation.